famotidine has been researched along with Glioblastoma in 1 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
Glioblastoma: A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horiuchi, Y | 1 |
| Bae, SJ | 1 |
| Katayama, I | 1 |
| Hayashi, Y | 1 |
1 other study available for famotidine and Glioblastoma
| Article | Year |
|---|---|
Unusual erythemas with eosinophilia, caused by H2-blocker famotidine in a male patient with glioblastoma.
Topics: Aged; Biopsy, Needle; Brain Neoplasms; Eosinophilia; Erythema; Famotidine; Follow-Up Studies; Gliobl | 2004 |